Study type

Study topic

Human medicinal product
Disease /health condition

Study type

Non-interventional study

Scope of the study

Drug utilisation

Data collection methods

Secondary use of data
Non-interventional study

Non-interventional study design

Other

Non-interventional study design, other

Retrospective database analysis
Study drug and medical condition

Study drug International non-proprietary name (INN) or common name

LEVONORGESTREL
NORETHISTERONE
NORGESTREL
DESOGESTREL
GESTODENE
NORGESTIMATE
ETONOGESTREL
DROSPIRENONE
DIENOGEST
CHLORMADINONE
NOMEGESTROL
NORELGESTROMIN

Medical condition to be studied

Contraception
Population studied

Short description of the study population

Women 15 - 49 years old who are recipients of at least one prescription of combined hormonal contraceptives containing 2nd, 3rd or 4th generation progestogens as recorded during the study period from January 1, 2002 to December 31, 2011 in the IMS Disease Analyser data of France, Germany and the UK.

Age groups

  • Adolescents (12 to < 18 years)
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)

Estimated number of subjects

1200000
Study design details

Main study objective

The main objective of this analysis is to describe the pattern of prescriptions of 3rd or 4th versus 2nd generation progestogen-combined contraceptives in France, Germany and the UK in the period from 1st January 2002 to 31 December 2011.

Data analysis plan

The analyses conducted are descriptive in nature. In each country the following was computed:• Proportion of women (all ages) receiving prescriptions for 3rd or 4th versus 2nd generation combined hormonal contraceptives stratified by 5 year age groups,• Proportion of women (15–49 years old) receiving prescriptions for 3rd or 4th versus 2nd generation combined hormonal contraceptives throughout the observation period and by calendar year 2002 through 2011.